Parex Resources Inc (PXT)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 30.13 |
|---|---|
| 52-week range | 17.12 – 30.44 |
| Return, 1 month / 3 months | +12.1% / +27.2% |
| Return, 1 year / 3 years | +76.0% / +54.3% |
| Trend | Uptrend |
| RSI (14) | 66 |
| Volatility (1 year) | 40.3% |
| Worst drawdown (1 year) | -29.3% |
| Average daily value traded | 21.48M CAD |
| Dividend yield | 5.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Parex Resources Inc is an oil and natural gas company based in Calgary, Alberta, Canada, whose operations are concentrated in Colombia. The company explores for, develops and produces crude oil and natural gas from onshore fields, principally in the Llanos Basin and other regions of the country. Its customers are the buyers of its crude oil and gas output, and it manages its Colombian assets through local operating subsidiaries and partnerships with other energy firms.
On this site Parex Resources Inc appears as a stock on the Toronto Exchange (Canada), code PXT, with prices in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Parex Resources Inc (PXT) trades on the Toronto Exchange in Canada. It last closed at CAD 30.13 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 44 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 76.0% and over the last three months it rose 27.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 92 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 23.0% | ||
| From 52-week high | 0.0% | ||
| Momentum | 84 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 27.2% | ||
| 6-month return | 13.8% | ||
| 12-month return, skipping the last month | 57.0% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.3% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 21.48M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.1% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.5% |
|---|---|
| 1 month | +12.1% |
| 3 months | +27.2% |
| 6 months | +13.8% |
| 1 year | +76.0% |
| 3 years | +54.3% |
| 5 years | +69.3% |
Signals
| 50-day / 200-day average | 27.89 / 24.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Sep 2026 | CAD 0.3850 |
| 8 Jun 2026 | CAD 0.3850 |
| 18 Mar 2026 | CAD 0.3850 |
| 8 Dec 2025 | CAD 0.3850 |
| 8 Sep 2025 | CAD 0.3850 |
| 9 Jun 2025 | CAD 0.3850 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.